Seeking Alpha

More on Ilumina (ILMN): Q1 beats across the board despite a slight decline in Y/Y revenue. Net...

More on Ilumina (ILMN): Q1 beats across the board despite a slight decline in Y/Y revenue. Net earnings actually rose 8.6% as the diagnostics company chalked up lower expenses to offset the revenue dip. Additionally, the company's board authorized a $250M share repurchase. Shares -0.8% AH.
Comments (1)
  • Mike Maher
    , contributor
    Comments (2481) | Send Message
     
    Instead of selling to Roche @ $51 management is going to start buying shares at 43? Where was the buyback in December with shares in the low $30s?
    23 Apr 2012, 10:52 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|